• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANOX LIMITED ORGANOX METRA; NORMOTHERMIC MACHINE PERFUSION SYSTEM FOR THE PRESERVATION OF DONOR LIVERS PRIOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANOX LIMITED ORGANOX METRA; NORMOTHERMIC MACHINE PERFUSION SYSTEM FOR THE PRESERVATION OF DONOR LIVERS PRIOR Back to Search Results
Catalog Number D0003
Medical Device Problem Code Restricted Flow rate (1248)
Health Effect - Clinical Code Liver Damage/Dysfunction (1954)
Date of Event 08/14/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Event data from the device was retrieved and reviewed.Evidence of downward trending flows beginning about one hour into the case was identified.However, root cause of the issue could not be determined from the data review.A service engineer evaluated the device at the customer site.The device was tested in both preparation and liver on board mode.The device consistently maintained and regulated pressures and flow rates as expected.The device passed all testing completed.
 
Event or Problem Description
The device user reported arterial flow was low.Initially the device was perfusing as they expected, but several hours into the perfusion the arterial flow began to taper off (from 0.4l/min to 0.1 l/min).They did various troubleshooting techniques to no avail.As a result, the liver was discarded.
 
Additional Manufacturer Narrative
Event data from the device was retrieved and reviewed.Evidence of downward trending flows beginning about one hour into the case was identified.However, root cause of the issue could not be determined from the data review.A service engineer evaluated the device at the customer site.The device was tested in both preparation and liver on board mode.The device consistently maintained and regulated pressures and flow rates as expected.The device passed all testing completed.
 
Event or Problem Description
The device user reported arterial flow was low.Initially the device was perfusing as they expected, but several hours into the perfusion the arterial flow began to taper off (from 0.4l/min to 0.1 l/min).They did various troubleshooting techniques to no avail.As a result, the liver was discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORGANOX METRA
Common Device Name
NORMOTHERMIC MACHINE PERFUSION SYSTEM FOR THE PRESERVATION OF DONOR LIVERS PRIOR
Manufacturer (Section D)
ORGANOX LIMITED
3500 john smith drive
oxford business park south
oxford, oxfordshire, gb OX4 2 WB
UK  OX4 2WB
MDR Report Key20205609
Report Number3022300078-2024-00016
Device Sequence Number17862452
Product Code QQK
UDI-Device Identifier05060462240005
UDI-Public5060462240005
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/12/2024
Report Date (Section F) 09/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberD0003
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date08/16/2024
Device Age9 MO
Event Location Hospital
Date Report to Manufacturer08/16/2024
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date09/12/2024
Supplement Report FDA Received Date09/12/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
Date Report Sent to FDA09/12/2024
-
-